Natalia Garcia-Casares
Overview
Explore the profile of Natalia Garcia-Casares including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramos-Cazorla P, Carazo-Barrios L, Reyes-Bueno J, Sagues-Sese E, de Rojas-Leal C, Barbancho M, et al.
J Diabetes Res
. 2024 Dec;
2024:9933957.
PMID: 39735414
Olfactory dysfunction and cognitive impairment (CI) have been associated with Type 2 diabetes (T2DM), but the mechanisms underlying this association are broadly unknown. This systematic review tends to investigate the...
2.
Reyes Bueno J, Sanchez-Guijo G, Raez P, Garcia-Arnes J, Garzon-Maldonado F, Castro V, et al.
J Alzheimers Dis
. 2024 May;
99(3):887-897.
PMID: 38758998
Background: Diabetes is one of the main risk factors for developing mild cognitive impairment (MCI) and Alzheimer's disease. Most studies have demonstrated a worse performance in executive function, verbal fluency,...
3.
Arrabal-Gomez C, Serrano-Castro P, Sanchez-Perez J, Garcia-Casares N, Fuxe K, Borroto-Escuela D, et al.
Expert Opin Ther Targets
. 2024 Apr;
28(4):309-322.
PMID: 38626283
Background: Major Depressive Disorder (MDD) poses a significant challenge to global health, with current treatments often limited by efficacy and onset delays. This study explores the synergistic antidepressant-like effects of...
4.
Beltran-Casanueva R, Hernandez-Garcia A, Serrano-Castro P, Sanchez-Perez J, Barbancho-Fernandez M, Garcia-Casares N, et al.
FASEB J
. 2024 Apr;
38(7):e23595.
PMID: 38572811
This study evaluates the sustained antidepressant-like effects and neurogenic potential of a 3-day intranasal co-administration regimen of galanin receptor 2 (GALR2) agonist M1145 and neuropeptide Y Y1 receptor (NPY1R) agonist...
5.
Sanchez-Varo R, Lopez-Salas A, Beltran-Casanueva R, Diaz-Sanchez E, Alvarez-Contino J, Barbancho-Fernandez M, et al.
Behav Brain Funct
. 2024 Mar;
20(1):6.
PMID: 38549164
Background: Spatial memory deficits and reduced neuronal survival contribute to cognitive decline seen in the aging process. Current treatments are limited, emphasizing the need for innovative therapeutic strategies. This research...
6.
Garcia-Alberca J, de Rojas I, Sanchez-Mejias E, Garrido-Martin D, Gonzalez-Palma L, Jimenez S, et al.
J Alzheimers Dis
. 2024 Mar;
98(2):601-618.
PMID: 38427484
Background: Microglial dysfunction plays a causative role in Alzheimer's disease (AD) pathogenesis. Here we focus on a germline insertion/deletion variant mapping SIRPβ1, a surface receptor that triggers amyloid-β(Aβ) phagocytosis via...
7.
Beltran-Casanueva R, Hernandez-Garcia A, de Amo Garcia P, Blanco-Reina E, Serrano-Castro P, Garcia-Casares N, et al.
Front Cell Neurosci
. 2024 Mar;
18:1323986.
PMID: 38425430
Introduction: This study may unveil novel insights into the interactions between neuropeptide Y receptor 1 (NPY1R) and galanin receptor 2 (GALR2), in the dentate gyrus of the dorsal hippocampus, shedding...
8.
Sagues-Sese E, Garcia-Casares N, Alvarez-Twose I
Clin Transl Allergy
. 2023 Dec;
13(12):e12319.
PMID: 38146805
Background: Mastocytosis manifests with multisystemic symptoms, often involving the nervous system. Numerous cognitive, neuropsychiatric and neurological alterations have been reported in multiple observational studies. Methods: We performed a qualitative systematic...
9.
Santos-Ortega A, Alba-Linero C, Urbinati F, Rocha-de-Lossada C, Orti R, Reyes-Bueno J, et al.
J Clin Med
. 2023 Nov;
12(22).
PMID: 38002648
Our objective is to analyze retinal changes using optical coherence tomography angiography (OCT-A) in patients with mild cognitive impairment (MCI) to characterize structural and vascular alterations. This cross-sectional study involved...
10.
Meszaros Crow E, Lopez-Gigosos R, Mariscal-Lopez E, Agredano-Sanchez M, Garcia-Casares N, Mariscal A, et al.
Front Psychol
. 2023 Jul;
14:1148805.
PMID: 37441329
Introduction: Cancer initiation, progression and recurrence are intricate mechanisms that depend on various components: genetic, psychophysiological, or environmental. Exposure to chronic stress includes fear of recurrence that can affect biological...